Unisphere Establishment’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9M Hold
7,500
– – 0.08% 47
2026
Q1
$6.9M Sell
7,500
-2,200
-23% -$2.23M 0.06% 46
2025
Q4
$10.4M Hold
9,700
– – 0.08% 45
2025
Q3
$7.4M Hold
9,700
– – 0.06% 52
2025
Q2
$7.56M Hold
9,700
– – 0.06% 50
2025
Q1
$8.01M Hold
9,700
– – 0.07% 46
2024
Q4
$7.49M Buy
9,700
+3,400
+54% +$2.82M 0.07% 49
2024
Q3
$5.58M Buy
+6,300
New +$5.66M 0.05% 56

Other funds holding LLY

Unisphere Establishment's LLY Position: Q2 2026 in Review

Unisphere Establishment held its Eli Lilly (LLY) position steady in Q2 2026 at 7,500 shares worth $9M. The position accounts for 0.08% of the portfolio, ranked #47.

Unisphere Establishment first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.4M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Unisphere Establishment held 7,500 shares of Eli Lilly worth $9M as of Q2 2026.
  • Unisphere Establishment left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.08% of Unisphere Establishment's portfolio in Q2 2026, its #47 holding.
  • Unisphere Establishment first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • Unisphere Establishment's Eli Lilly position peaked at $10.4M in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Unisphere Establishment's 13F filing for Q2 2026, filed 14 Aug 2026.